Biotech stocks offer risks, payoffs – Sun, 11 Jan 2015 PST

You might want to invest in biotechnology, but be careful. Its not an easy industry to master, and while some companies eventually skyrocket, many others flameout.

One simple way to invest in biotech is the iShares Nasdaq Biotechnology ETF (Nasdaq: IBB), which is a fund of roughly 150 stocks that has grown by an annual average of almost 15 percent over the pastdecade.

If youre willing to take on more risk for a chance at a bigger reward, consider Celgene (Nasdaq: CELG), which sells the pancreatic cancer drug Abraxane. Many balk at its steep price, but

You have viewed 20 free articles or blogs allowed within a 30-day period. FREE registration is now required for uninterrupted access.

S-R Media, The Spokesman-Review and Spokesman.com are happy to assist you. Contact Customer Service by email or call 800-338-8801

File photo

Biotechnology is not an easy industry tomaster. (Full-size photo)

You might want to invest in biotechnology, but be careful. Its not an easy industry to master, and while some companies eventually skyrocket, many others flameout.

One simple way to invest in biotech is the iShares Nasdaq Biotechnology ETF (Nasdaq: IBB), which is a fund of roughly 150 stocks that has grown by an annual average of almost 15 percent over the pastdecade.

If youre willing to take on more risk for a chance at a bigger reward, consider Celgene (Nasdaq: CELG), which sells the pancreatic cancer drug Abraxane. Many balk at its steep price, but pancreatic cancer is notoriously tough to treat, and its unlikely that doctors or patients will stop using it in the absence of otheroptions.

Read more:
Biotech stocks offer risks, payoffs - Sun, 11 Jan 2015 PST